Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Designing nanostructured lipid carriers modified with folate-conjugated chitosan for targeted delivery of osthole to HT-29 colon cancer cells: investigation of anticancer, antioxidant, and antibacterial activities

Fig. 3

Cytotoxic effects of OST-NCF-NPs. A Viability rate of HT-29 and HFF cell lines in comparison to control after exposure to various OST-NCF-NPs concentrations (31.2, 62.5, 125, 250, and 500 µg/mL). The treatment resulted in reduced cell viability, indicating the specific toxic effect of OST-NCF-NPs on the HT-29 cell line. B The morphology of treated HT-29 cancer cells under specific OST-NCF-NPs doses (65 and 115 µg/mL) compared to the untreated group. The *** denotes the level of a statistical significance level of < 0.001. (N = 3). OST-NCF-NPs: Nanostructured lipid carriers coated with chitosan conjugated folate nanoparticles containing Osthole; MTT: 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us